Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.26 USD | +5.16% | +4.82% | +97.58% |
May. 09 | Generation Bio Co. Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms At the ASGCT 27th Annual Meeting | CI |
Apr. 12 | Transcript : Generation Bio Co. - Special Call |
Financials (USD)
Sales 2024 * | 5.59M | Sales 2025 * | 4.77M | Capitalization | 206M |
---|---|---|---|---|---|
Net income 2024 * | -86M | Net income 2025 * | -97M | EV / Sales 2024 * | 9.33 x |
Net cash position 2024 * | 154M | Net cash position 2025 * | - | EV / Sales 2025 * | 43.2 x |
P/E ratio 2024 * |
-2.22
x | P/E ratio 2025 * |
-2.38
x | Employees | 174 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.43% |
Latest transcript on Generation Bio Co.
1 day | +5.16% | ||
1 week | +4.82% | ||
Current month | +15.19% | ||
1 month | -18.09% | ||
3 months | +62.19% | ||
6 months | +213.46% | ||
Current year | +97.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 17-09-30 | |
Matthew Norkunas
DFI | Director of Finance/CFO | 46 | 20-07-21 |
Antoinette Paone
COO | Chief Operating Officer | 46 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 18-04-30 |
Director/Board Member | 76 | 17-11-30 | |
Jason Rhodes
FOU | Founder | 54 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 3.1 | -2.52% | 58,899 |
24-05-07 | 3.18 | -5.07% | 146,158 |
24-05-06 | 3.35 | +5.68% | 247,769 |
24-05-03 | 3.17 | +1.93% | 63,938 |
24-05-02 | 3.11 | +6.87% | 410,903 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+97.58% | 206M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- GBIO Stock